MetLife, Inc. $MET Shares Acquired by Aspiriant LLC

Aspiriant LLC grew its position in MetLife, Inc. (NYSE:MET) by 15.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,866 shares of the financial services provider’s stock after acquiring an additional 530 shares during the quarter. Aspiriant LLC’s holdings in MetLife were worth $311,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Kathmere Capital Management LLC lifted its stake in MetLife by 88.2% in the second quarter. Kathmere Capital Management LLC now owns 6,328 shares of the financial services provider’s stock valued at $509,000 after buying an additional 2,965 shares during the last quarter. First Horizon Advisors Inc. lifted its position in MetLife by 4.8% in the 1st quarter. First Horizon Advisors Inc. now owns 422,684 shares of the financial services provider’s stock valued at $33,937,000 after purchasing an additional 19,192 shares during the last quarter. Pinnacle Financial Partners Inc acquired a new position in MetLife during the 1st quarter valued at about $255,000. Mirae Asset Global Investments Co. Ltd. grew its position in MetLife by 20.7% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 60,785 shares of the financial services provider’s stock worth $4,735,000 after purchasing an additional 10,414 shares during the last quarter. Finally, Heartland Bank & Trust Co acquired a new stake in shares of MetLife in the first quarter valued at approximately $516,000. 94.99% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. Barclays upped their price objective on shares of MetLife from $93.00 to $98.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Wolfe Research raised shares of MetLife to a “strong-buy” rating in a research note on Tuesday, September 16th. Cowen reiterated a “buy” rating on shares of MetLife in a research note on Friday, August 22nd. Piper Sandler cut MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 target price on the stock. in a report on Friday, September 19th. Finally, Jefferies Financial Group lifted their price target on MetLife from $100.00 to $103.00 and gave the company a “buy” rating in a research report on Monday, August 11th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $95.18.

MetLife Stock Performance

NYSE:MET opened at $78.55 on Friday. The firm’s 50-day moving average is $80.20 and its 200-day moving average is $78.08. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.16 and a current ratio of 0.16. The company has a market cap of $52.24 billion, a price-to-earnings ratio of 13.31, a PEG ratio of 0.71 and a beta of 0.86. MetLife, Inc. has a 52-week low of $65.21 and a 52-week high of $89.05.

MetLife (NYSE:MET) last announced its quarterly earnings data on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.32 by ($0.30). MetLife had a net margin of 5.83% and a return on equity of 19.88%. The business had revenue of $17.34 billion during the quarter, compared to analyst estimates of $18.58 billion. During the same quarter in the prior year, the company posted $2.28 EPS. The company’s quarterly revenue was down 2.7% compared to the same quarter last year. Equities research analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 9th. Investors of record on Tuesday, November 4th will be paid a dividend of $0.5675 per share. The ex-dividend date of this dividend is Tuesday, November 4th. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.9%. MetLife’s payout ratio is 38.47%.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.